Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study

The multinational, observational CVD‐REAL study recently showed that initiation of sodium‐glucose co‐transporter‐2 inhibitors (SGLT‐2i) was associated with significantly lower rates of death and heart failure vs other glucose‐lowering drugs (oGLDs). This sub‐analysis of the CVD‐REAL study sought to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosiborod, Mikhail, Birkeland, Kåre I., Cavender, Matthew A., Fu, Alex Z., Wilding, John P., Khunti, Kamlesh, Holl, Reinhard W., Norhammar, Anna, Jørgensen, Marit E., Wittbrodt, Eric T., Thuresson, Marcus, Bodegård, Johan, Hammar, Niklas, Fenici, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055705/
https://www.ncbi.nlm.nih.gov/pubmed/29569378
http://dx.doi.org/10.1111/dom.13299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055705/
https://www.ncbi.nlm.nih.gov/pubmed/29569378
http://dx.doi.org/10.1111/dom.13299

Ejemplares similares